A master cancer gene hijacks a ‘molecular crowbar’ to make breast cancer cells invasive January 22, 2021
The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
A master cancer gene hijacks a ‘molecular crowbar’ to make breast cancer cells invasive January 22, 2021
The price of a drug should be based on its therapeutic benefits – not just what the market will bear January 19, 2021
Gynaecologic Cancers Secondary surgery does not improve overall survival for recurrent ovarian cancer patients November 14, 2019 Researchers from The University of Texas MD Anderson Cancer Center reported that secondary tumour-reduction, or…